Metabolic dysfunction-associated steatotic liver disease: Where does non-alcoholic fatty liver disease in liver transplant recipients fit in this new definition?
J Hepatol
.
2024 Feb;80(2):e77-e79.
doi: 10.1016/j.jhep.2023.09.009.
Epub 2023 Sep 16.
Authors
Narendra Singh Choudhary
1
,
Swapnil Dhampalwar
2
,
Neeraj Saraf
2
,
Arvinder S Soin
2
Affiliations
1
Institute of Liver Transplantation & Regenerative Medicine, Medanta- The Medicity, Gurugram, India. Electronic address: docnarendra@gmail.com.
2
Institute of Liver Transplantation & Regenerative Medicine, Medanta- The Medicity, Gurugram, India.
PMID:
37717602
DOI:
10.1016/j.jhep.2023.09.009
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Liver Transplantation* / adverse effects
Metabolic Diseases*
Non-alcoholic Fatty Liver Disease* / complications
Non-alcoholic Fatty Liver Disease* / diagnosis